Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H25NO2 |
Molecular Weight | 287.3966 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12CC3=C(C=C(O)C=C3)[C@](C)(CCN1CC4CC4)[C@H]2OC
InChI
InChIKey=IOZWXJXXVLARQC-SQNIBIBYSA-N
InChI=1S/C18H25NO2/c1-18-7-8-19(11-12-3-4-12)16(17(18)21-2)9-13-5-6-14(20)10-15(13)18/h5-6,10,12,16-17,20H,3-4,7-9,11H2,1-2H3/t16-,17+,18+/m1/s1
Molecular Formula | C18H25NO2 |
Molecular Weight | 287.3966 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Moxazocine is a benzomorphan derivative patented by Bristol-Myers Co. as potent opioid analgesic. Moxazocine acts as a partial agonist or mixed agonist/antagonist of the opioid receptors and binds preferentially to the κ-opioid receptor. In clinical studies, Moxazocine demonstrated superior efficacy compared morphine, but was never marketed.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://psycnet.apa.org/record/1978-23576-001
0.5 and 1.0 mg
Route of Administration:
Intravenous
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:15:43 UTC 2023
by
admin
on
Fri Dec 15 17:15:43 UTC 2023
|
Record UNII |
BNB57S7DWT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID80866681
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
PRIMARY | |||
|
BNB57S7DWT
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
PRIMARY | |||
|
C90644
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
PRIMARY | |||
|
100000080597
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
PRIMARY | |||
|
3047776
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
PRIMARY | |||
|
4359
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
PRIMARY | |||
|
58239-89-7
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
PRIMARY | |||
|
SUB09083MIG
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
PRIMARY | |||
|
CHEMBL2107102
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
PRIMARY | |||
|
Moxazocine
Created by
admin on Fri Dec 15 17:15:43 UTC 2023 , Edited by admin on Fri Dec 15 17:15:43 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |